Infant Formula Market Report, Global Industry Analysis, Market Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030

  • Published Date: Jan, 2024
  • Report ID: CR0195519
  • Format: Electronic (PDF)
  • Number of Pages: 177
  • Author(s): Joshi, Madhavi

Report Overview

The Infant Formula Market size was estimated at USD 45 billion in 2023 and is projected to reach USD 65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.10% during the forecast period (2024-2030).

Infant Formula Market

(Market Size)
$45 billion
$65 billion
2023
2030
Source: Citius Research
Study Period 2018 - 2030
Base Year For Estimation 2023
Forecast Data Period 2024 - 2030
CAGR (2024-2030) 7.10%
2023 Market Size USD 45 billion
2030 Market Size USD 65 billion
Key Players Nestlé, Danone, Reckitt Benckiser, Abbott, Mead Johnson

Market Summary

The infant formula market represents a critical segment within the global food and beverages industry, catering to the nutritional needs of infants who are not breastfed. This market is characterized by stringent regulatory frameworks and high-quality standards due to the sensitive nature of its consumer base. Products are scientifically formulated to mimic human breast milk as closely as possible, providing essential nutrients for healthy growth and development. The industry is highly competitive and innovation-driven, with manufacturers continuously investing in research and development to enhance product formulations. Key product categories include standard, follow-on, and specialty formulas designed for infants with specific dietary requirements or medical conditions. The demand is largely influenced by rising birth rates in emerging economies, increasing female workforce participation, and growing awareness about infant nutrition. Distribution channels are diverse, spanning supermarkets, hypermarkets, pharmacies, and online platforms, ensuring wide product accessibility. The market's dynamics are further shaped by evolving consumer preferences towards organic and clean-label products, prompting companies to expand their portfolios accordingly.

Key Highlights

The infant formula market is distinguished by several key highlights that underscore its significance and operational nuances. A primary feature is the intense focus on product safety and nutritional adequacy, governed by rigorous international and national regulations from bodies like the FDA and EFSA. Innovation remains a cornerstone, with leading companies investing heavily in advanced technologies to develop formulas containing novel ingredients such as prebiotics, probiotics, and human milk oligosaccharides (HMOs) that support immune health and cognitive development. The competitive landscape is dominated by a few multinational giants, including Nestl?, Danone, and Reckitt Benckiser, which command substantial market share through extensive brand portfolios and global distribution networks. Another highlight is the growing consumer inclination towards organic and plant-based infant formulas, driven by heightened health consciousness and environmental concerns. The market also exhibits robust growth in e-commerce, with online sales becoming an increasingly vital channel for product discovery and purchase. Additionally, strategic initiatives such as mergers, acquisitions, and partnerships are prevalent as companies seek to expand their geographic footprint and enhance their technological capabilities.

Drivers, Opportunities & Restraints

Several drivers propel the infant formula market forward, including rising global birth rates, particularly in Asia-Pacific and Africa, which expand the consumer base. Increasing female labor force participation rates globally reduce the duration of breastfeeding, thereby boosting reliance on formula products. Growing parental awareness regarding the importance of early-life nutrition and the availability of specialized formulas for allergies and metabolic disorders further stimulate demand. Opportunities abound in the development of innovative products tailored to specific nutritional needs, such as formulas fortified with omega-3 fatty acids for brain development or those made from organic ingredients to appeal to health-conscious consumers. Emerging markets present significant growth potential due to improving economic conditions, urbanization, and expanding retail infrastructure. However, the market faces restraints, including intense scrutiny from regulatory bodies which can delay product launches and increase compliance costs. High product costs may limit adoption in low-income regions, and persistent concerns about product safety, occasionally exacerbated by recalls, can erode consumer trust. Additionally, strong promotion of breastfeeding by health organizations poses a challenge to market expansion in some demographics.

Concentration Insights

The infant formula market exhibits a high level of concentration, with a few major players dominating the global landscape. Companies such as Nestl? SA, Danone SA, Reckitt Benckiser Group plc, Abbott Laboratories, and Mead Johnson Nutrition hold significant market shares due to their extensive research capabilities, strong brand recognition, and vast distribution networks. These industry leaders leverage their financial strength to invest in cutting-edge research and development, enabling them to introduce advanced products that meet evolving consumer demands and regulatory standards. Their dominance is reinforced by strategic acquisitions and partnerships aimed at expanding product portfolios and geographic reach. For instance, companies often acquire smaller niche brands specializing in organic or specialty formulas to capture growing market segments. Despite this concentration, the market also features numerous regional and private-label players that compete on price and cater to local preferences. The competitive intensity ensures continuous innovation and marketing efforts, but high barriers to entry, including stringent regulatory approvals and substantial capital requirements, protect the positions of established incumbents.

Type Insights

Infant formula products are segmented into various types based on their formulation and intended use, catering to diverse nutritional needs. Standard milk-based formulas constitute the largest segment, designed to serve as a nutritional substitute for breast milk for healthy, full-term infants. These products are typically derived from cow's milk and fortified with vitamins, minerals, and essential fatty acids. Follow-on formulas are intended for infants aged six months and older, providing adjusted nutrient levels to complement the introduction of solid foods. Specialty formulas represent a rapidly growing category, formulated to address specific medical conditions or dietary requirements. This includes hypoallergenic formulas for infants with cow's milk protein allergy, lactose-free formulas for those with lactose intolerance, and soy-based formulas for vegan families or infants with dairy sensitivities. Additionally, there are formulas enriched with prebiotics and probiotics to support digestive health, and those fortified with nucleotides and antioxidants to enhance immune function. The rising demand for organic and clean-label products has also led to the proliferation of formulas made from organic milk or plant-based ingredients, free from synthetic pesticides and genetically modified organisms.

Application Insights

The application of infant formula is primarily categorized based on the age group and specific needs of the infant. The market serves newborns (0-6 months) with starter formulas that are nutritionally complete and designed to be the sole source of nutrition. For infants aged 6-12 months, follow-on formulas are used to supplement solid foods, providing additional iron, calcium, and other nutrients critical during this growth phase. Toddler formulas, intended for children over 12 months, support continued development and are often fortified with DHA and ARA for brain and eye health. Beyond age-specific applications, there are specialized formulas for medical purposes, such as those for preterm or low-birth-weight infants, which have higher calorie and nutrient densities. Formulas are also tailored for infants with metabolic disorders like phenylketonuria (PKU), requiring specific amino acid profiles. Furthermore, the growing awareness of gastrointestinal health has increased the use of probiotic and prebiotic-enriched formulas to alleviate issues like colic and constipation. The application spectrum is expanding with products that target cognitive development, immune support, and overall wellness, reflecting advanced scientific understanding and consumer demand for tailored nutritional solutions.

Regional Insights

The infant formula market demonstrates distinct regional dynamics influenced by demographic trends, economic conditions, and cultural factors. The Asia-Pacific region dominates globally, driven by high birth rates in countries like China and India, rising disposable incomes, and strong cultural acceptance of formula feeding. China, in particular, is a critical market due to its large population and recovery from past food safety scandals, leading to heightened demand for premium and imported brands. North America and Europe are mature markets characterized by stringent regulations, high consumer awareness, and a preference for organic and specialty products. In these regions, demand is bolstered by working mothers and the availability of advanced formulations. Latin America shows promising growth, fueled by economic development, urbanization, and expanding retail networks. The Middle East and Africa present emerging opportunities, with increasing birth rates and improving healthcare infrastructure driving demand, though economic disparities may affect market penetration. Regional regulatory differences significantly impact market entry and product strategies, with companies adapting formulations to meet local standards and cultural preferences, such as halal certification in Muslim-majority countries.

Company Insights

The competitive landscape of the infant formula market is shaped by a blend of multinational corporations and specialized players. Nestl? SA, through its Gerber and Nestl? Nan brands, maintains a leadership position with a comprehensive portfolio spanning standard and specialty formulas. Danone SA, owning brands like Aptamil and Nutrilon, emphasizes innovation in early-life nutrition, particularly in probiotic and organic segments. Reckitt Benckiser Group plc, with its Mead Johnson Enfamily portfolio, focuses on scientific research to develop products supporting immune and brain development. Abbott Laboratories leverages its Similac brand to offer advanced formulations with HMOs and other proprietary blends. These companies invest heavily in clinical research to validate health claims and differentiate their products. Beyond these giants, companies like Perrigo Company plc play a significant role in manufacturing private-label formulas for retailers, offering cost-competitive alternatives. Emerging players, such as Bobbie and Happy Family Organics, target niche segments like organic and subscription-based models, disrupting traditional distribution. Strategic activities, including mergers, acquisitions, and geographic expansions, are common as firms seek to enhance their market presence and technological capabilities in this high-stakes industry.

Recent Developments

The infant formula market has witnessed several significant recent developments reflecting ongoing innovation and strategic shifts. Leading companies have intensified their focus on sustainability, introducing eco-friendly packaging and initiatives to reduce carbon footprints across the supply chain. Product innovation continues to advance, with launches of formulas containing novel ingredients like lactoferrin and specific HMOs designed to closely replicate the benefits of breast milk. There has been a notable increase in the availability of clean-label and organic products, responding to consumer demand for transparency and natural ingredients. Geopolitical events and trade policies have impacted supply chains, prompting companies to diversify manufacturing locations to mitigate risks. Regulatory changes in key markets, such as updated nutrient requirements and stricter marketing codes, have compelled manufacturers to reformulate products and adjust their promotional strategies. Additionally, the industry has seen heightened merger and acquisition activity, with larger entities acquiring niche brands to bolster their specialty and organic offerings. The e-commerce channel has expanded rapidly, with brands enhancing their digital presence and direct-to-consumer capabilities to meet evolving shopping behaviors and reach underserved regions.

Report Segmentation

This market research report on the infant formula industry provides a detailed segmentation to offer comprehensive insights into various market dimensions. The segmentation by type includes standard infant formula, follow-on formula, and specialty formula, with further breakdowns into subcategories such as milk-based, soy-based, hypoallergenic, and organic variants. By application, the report covers age groups including 0-6 months, 6-12 months, and 12-36 months, as well as specialized applications for preterm infants and those with medical conditions. Distribution channel segmentation encompasses supermarkets and hypermarkets, pharmacies, online stores, and others, analyzing the shifting preferences and growth rates across these avenues. Geographically, the report is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, with country-level analysis for major markets such as the United States, China, Germany, and Brazil. Additionally, the report may segment the market by ingredient focus, such as formulas with added probiotics, prebiotics, or specific fatty acids, providing insights into trending nutritional enhancements. This multi-faceted segmentation enables stakeholders to identify growth opportunities, understand competitive dynamics, and make informed strategic decisions based on granular market data.

FAQs

What is the difference between organic and conventional infant formula? Organic infant formula is produced using milk from cows that are raised according to organic farming standards, which prohibit the use of synthetic pesticides, antibiotics, and genetically modified organisms. Conventional formulas may contain these elements. Organic options often appeal to parents seeking natural and environmentally sustainable products, though both types must meet strict nutritional and safety regulations.

How do I choose the right infant formula? Selecting the appropriate infant formula depends on the baby's age, health status, and dietary needs. For healthy, term infants, standard milk-based formulas are typically suitable. Those with allergies may require hypoallergenic or soy-based options. Consulting a pediatrician is crucial to address specific concerns like lactose intolerance, reflux, or prematurity, ensuring the chosen product supports optimal growth and development.

Are there infant formulas for babies with allergies? Yes, specialized infant formulas are available for babies with allergies, particularly cow's milk protein allergy. These include extensively hydrolyzed formulas, where proteins are broken down to avoid allergic reactions, and amino acid-based formulas for severe cases. Soy-based formulas are another alternative, though some infants with milk allergies may also react to soy, necessitating professional medical advice before use.

What are the key ingredients to look for in infant formula? Key ingredients in quality infant formulas include proteins, fats, and carbohydrates calibrated to mimic breast milk, along with essential vitamins and minerals. Important functional ingredients may comprise docosahexaenoic acid (DHA) and arachidonic acid (ARA) for brain and eye development, prebiotics and probiotics for digestive health, and iron to prevent anemia. Always ensure the formula complies with regulatory standards for infant nutrition.

How is infant formula regulated for safety? Infant formula is strictly regulated by government agencies such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA). These bodies set rigorous standards for nutritional content, labeling, and manufacturing practices to ensure product safety and adequacy. Manufacturers must conduct testing for contaminants and adhere to Good Manufacturing Practices (GMP), with regular inspections to enforce compliance and protect infant health.

Citius Research has developed a research report titled “Infant Formula Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030” delivering key insights regarding business intelligence and providing concrete business strategies to clients in the form of a detailed syndicated report. The report details out the factors such as business environment, industry trend, growth opportunities, competition, pricing, global and regional market analysis, and other market related factors.

Details included in the report for the years 2024 through 2030

• Infant Formula Market Potential
• Segment-wise breakup
• Compounded annual growth rate (CAGR) for the next 6 years
• Key customers and their preferences
• Market share of major players and their competitive strength
• Existing competition in the market
• Price trend analysis
• Key trend analysis
• Market entry strategies
• Market opportunity insights

The report focuses on the drivers, restraints, opportunities, and challenges in the market based on various factors geographically. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. The Infant Formula Market report is segmented on the basis of various market segments and their analysis, both in terms of value and volume, for each region for the period under consideration.

Infant Formula Market Segmentation

Market Segmentation

Regions Covered

• North America
• Latin America
• Europe
• MENA
• Asia Pacific
• Sub-Saharan Africa and
• Australasia

Infant Formula Market Analysis

The report covers below mentioned analysis, but is not limited to:

• Overview of Infant Formula Market
• Research Methodology
• Executive Summary
• Market Dynamics of Infant Formula Market
  • Driving Factors
  • Restraints
  • Opportunities
• Global Market Status and Forecast by Segment A
• Global Market Status and Forecast by Segment B
• Global Market Status and Forecast by Segment C
• Global Market Status and Forecast by Regions
• Upstream and Downstream Market Analysis of Infant Formula Market
• Cost and Gross Margin Analysis of Infant Formula Market
• Infant Formula Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030
  • Competition Landscape
  • Market Share of Major Players
• Key Recommendations

The “Infant Formula Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030” report helps the clients to take business decisions and to understand strategies of major players in the industry. The report delivers the market driven results supported by a mix of primary and secondary research. The report provides the results triangulated through authentic sources and upon conducting thorough primary interviews with the industry experts. The report includes the results on the areas where the client can focus and create point of parity and develop a competitive edge, based on real-time data results.

Infant Formula Market Key Stakeholders

Below are the key stakeholders for the Infant Formula Market:

• Manufacturers
• Distributors/Traders/Wholesalers
• Material/Component Manufacturers
• Industry Associations
• Downstream vendors

Infant Formula Market Report Scope

Report AttributeDetails
Base year2023
Historical data2018 – 2023
Forecast2024 - 2030
CAGR2024 - 2030
Quantitative UnitsValue (USD Million)
Report coverageRevenue Forecast, Competitive Landscape, Growth Factors, Trends and Strategies. Customized report options available on request
Segments coveredProduct type, technology, application, geography
Regions coveredNorth America, Latin America, Europe, MENA, Asia Pacific, Sub-Saharan Africa and Australasia
Countries coveredUS, UK, China, Japan, Germany, India, France, Brazil, Italy, Canada, Russia, South Korea, Australia, Spain, Mexico and others
Customization scopeAvailable on request
PricingVarious purchase options available as per your research needs. Discounts available on request

COVID-19 Impact Analysis

Like most other markets, the outbreak of COVID-19 had an unfavorable impact on the Infant Formula Market worldwide. This report discusses in detail the disruptions experienced by the market, the impact on flow of raw materials, manufacturing operations, production trends, consumer demand and the projected future of this market post pandemic.

The report has helped our clients:

• To describe and forecast the Infant Formula Market size, on the basis of various segmentations and geography, in terms of value and volume
• To measure the changing needs of customers/industries
• To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the market
• To gain competitive intelligence and uncover new opportunities
• To analyse opportunities in the market for stakeholders by identifying high-growth segments in Infant Formula Market
• To strategically profile key players and provide details of the current competitive landscape
• To analyse strategic approaches adopted by players in the market, such as product launches and developments, acquisitions, collaborations, contracts, expansions, and partnerships

Report Customization

Citius Research provides free customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Customize This Report

Frequently Asked Questions

The Global Infant Formula Market size was valued at $XX billion in 2023 and is anticipated to reach $XX billion by 2030 growing at a CAGR of XX%
The global Infant Formula Market is expected to grow at a CAGR of XX% from 2023 to 2030.
For further details request a free sample copy of this report here.
For further details request a free sample copy of this report here.
For further details request a free sample copy of this report here.
For further details request a free sample copy of this report here.

Table of Contents

Chapter 1. Introduction
  1.1. Market Scope
  1.2. Key Segmentations
  1.3. Research Objective
Chapter 2. Research Methodology & Assumptions
Chapter 3. Executive Summary
Chapter 4. Market Background
  4.1. Dynamics
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunity
    4.1.4. Challenges
  4.2. Key Trends in the Impacting the Market
    4.2.1. Demand & Supply
  4.3. Industry SWOT Analysis
  4.4. Porter’s Five Forces Analysis
  4.5. Value and Supply Chain Analysis
  4.6. Macro-Economic Factors
  4.7. COVID-19 Impact Analysis
    4.7.1. Global and Regional Assessment
  4.8. Profit Margin Analysis
  4.9. Trade Analysis
    4.9.1. Importing Countries
    4.9.2. Exporting Countries
  4.10. Market Entry Strategies
  4.11. Market Assessment (US$ Mn and Units)
Chapter 5. Global Infant Formula Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Segment A
  5.1. By Segment A, 2024 - 2030
    5.1.1. Sub-Segment A
    5.1.2. Sub-Segment B
  5.2. Opportunity Analysis
Chapter 6. Global Infant Formula Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Segment B
  6.1. By Segment B, 2024 - 2030
    6.1.1. Sub-Segment A
    6.1.2. Sub-Segment B
  6.2. Opportunity Analysis
Chapter 7. Global Infant Formula Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Segment C
  7.1. By Segment C, 2024 - 2030
    7.1.1. Sub-Segment A
    7.1.2. Sub-Segment B
  7.2. Opportunity Analysis
Chapter 8. Global Infant Formula Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Region
  8.1. By Region, 2024 - 2030
    8.1.1. North America
    8.1.2. Latin America
    8.1.3. Europe
    8.1.4. MENA
    8.1.5. Asia Pacific
    8.1.6. Sub-Saharan Africa
    8.1.7. Australasia
  8.2. Opportunity Analysis
Chapter 9. North America Infant Formula Market Forecast and Trend Analysis
  9.1. Regional Overview
  9.2. Pricing Analysis
  9.3. Key Trends in the Region
    9.3.1. Supply and Demand
  9.4. Demographic Structure
  9.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    9.5.1. Sub-Segment A
    9.5.2. Sub-Segment B
  9.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    9.6.1. Sub-Segment A
    9.6.2. Sub-Segment B
  9.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    9.7.1. Sub-Segment A
    9.7.2. Sub-Segment B
  9.8. By Country, 2024 - 2030, (US$ Mn and Units)
    9.8.1. U.S.
    9.8.2. Canada
    9.8.3. Rest of North America
  9.9. Opportunity Analysis
Chapter 10. Latin America Infant Formula Market Forecast and Trend Analysis
  10.1. Regional Overview
  10.2. Pricing Analysis
  10.3. Key Trends in the Region
    10.3.1. Supply and Demand
  10.4. Demographic Structure
  10.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    10.5.1. Sub-Segment A
    10.5.2. Sub-Segment B
  10.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    10.6.1. Sub-Segment A
    10.6.2. Sub-Segment B
  10.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    10.7.1. Sub-Segment A
    10.7.2. Sub-Segment B
  10.8. By Country, 2024 - 2030, (US$ Mn and Units)
    10.8.1. Brazil
    10.8.2. Argentina
    10.8.3. Rest of Latin America
  10.9. Opportunity Analysis
Chapter 11. Europe Infant Formula Market Forecast and Trend Analysis
  11.1. Regional Overview
  11.2. Pricing Analysis
  11.3. Key Trends in the Region
    11.3.1. Supply and Demand
  11.4. Demographic Structure
  11.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    11.5.1. Sub-Segment A
    11.5.2. Sub-Segment B
  11.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    11.6.1. Sub-Segment A
    11.6.2. Sub-Segment B
  11.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    11.7.1. Sub-Segment A
    11.7.2. Sub-Segment B
  11.8. By Country, 2024 - 2030, (US$ Mn and Units)
    11.8.1. UK
    11.8.2. Germany
    11.8.3. France
    11.8.4. Spain
    11.8.5. Rest of Europe
  11.9. Opportunity Analysis
Chapter 12. MENA Infant Formula Market Forecast and Trend Analysis
  12.1. Regional Overview
  12.2. Pricing Analysis
  12.3. Key Trends in the Region
    12.3.1. Supply and Demand
  12.4. Demographic Structure
  12.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    12.5.1. Sub-Segment A
    12.5.2. Sub-Segment B
  12.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    12.6.1. Sub-Segment A
    12.6.2. Sub-Segment B
  12.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    12.7.1. Sub-Segment A
    12.7.2. Sub-Segment B
  12.8. By Country, 2024 - 2030, (US$ Mn and Units)
    12.8.1. Egypt
    12.8.2. Algeria
    12.8.3. GCC
    12.8.4. Rest of MENA
  12.9. Opportunity Analysis
Chapter 13. Asia Pacific Infant Formula Market Forecast and Trend Analysis
  13.1. Regional Overview
  13.2. Pricing Analysis
  13.3. Key Trends in the Region
    13.3.1. Supply and Demand
  13.4. Demographic Structure
  13.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    13.5.1. Sub-Segment A
    13.5.2. Sub-Segment B
  13.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    13.6.1. Sub-Segment A
    13.6.2. Sub-Segment B
  13.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    13.7.1. Sub-Segment A
    13.7.2. Sub-Segment B
  13.8. By Country, 2024 - 2030, (US$ Mn and Units)
    13.8.1. India
    13.8.2. China
    13.8.3. Japan
    13.8.4. ASEAN
    13.8.5. Rest of Asia Pacific
  13.9. Opportunity Analysis
Chapter 14. Sub-Saharan Africa Infant Formula Market Forecast and Trend Analysis
  14.1. Regional Overview
  14.2. Pricing Analysis
  14.3. Key Trends in the Region
    14.3.1. Supply and Demand
  14.4. Demographic Structure
  14.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    14.5.1. Sub-Segment A
    14.5.2. Sub-Segment B
  14.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    14.6.1. Sub-Segment A
    14.6.2. Sub-Segment B
  14.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    14.7.1. Sub-Segment A
    14.7.2. Sub-Segment B
  14.8. By Country, 2024 - 2030, (US$ Mn and Units)
    14.8.1. Ethiopia
    14.8.2. Nigeria
    14.8.3. Rest of Sub-Saharan Africa
  14.9. Opportunity Analysis
Chapter 15. Australasia Infant Formula Market Forecast and Trend Analysis
  15.1. Regional Overview
  15.2. Pricing Analysis
  15.3. Key Trends in the Region
    15.3.1. Supply and Demand
  15.4. Demographic Structure
  15.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    15.5.1. Sub-Segment A
    15.5.2. Sub-Segment B
  15.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    15.6.1. Sub-Segment A
    15.6.2. Sub-Segment B
  15.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    15.7.1. Sub-Segment A
    15.7.2. Sub-Segment B
  15.8. By Country, 2024 - 2030, (US$ Mn and Units)
    15.8.1. Australia
    15.8.2. New Zealand
    15.8.3. Rest of Australasia
  15.9. Opportunity Analysis
Chapter 16. Competition Analysis
  16.1. Competitive Benchmarking
    16.1.1. Top Player’s Market Share
    16.1.2. Price and Product Comparison
  16.2. Company Profiles
    16.2.1. Company A
      16.2.1.1. Company Overview
      16.2.1.2. Segmental Revenue
      16.2.1.3. Product Portfolio
      16.2.1.4. Key Developments
      16.2.1.5. Strategic Outlook
    16.2.2. Company B
      16.2.2.1. Company Overview
      16.2.2.2. Segmental Revenue
      16.2.2.3. Product Portfolio
      16.2.2.4. Key Developments
      16.2.2.5. Strategic Outlook
    16.2.3. Company C
      16.2.3.1. Company Overview
      16.2.3.2. Segmental Revenue
      16.2.3.3. Product Portfolio
      16.2.3.4. Key Developments
      16.2.3.5. Strategic Outlook
    16.2.4. Company D
      16.2.4.1. Company Overview
      16.2.4.2. Segmental Revenue
      16.2.4.3. Product Portfolio
      16.2.4.4. Key Developments
      16.2.4.5. Strategic Outlook
    16.2.5. Company E
      16.2.5.1. Company Overview
      16.2.5.2. Segmental Revenue
      16.2.5.3. Product Portfolio
      16.2.5.4. Key Developments
      16.2.5.5. Strategic Outlook
    16.2.6. Company F
      16.2.6.1. Company Overview
      16.2.6.2. Segmental Revenue
      16.2.6.3. Product Portfolio
      16.2.6.4. Key Developments
      16.2.6.5. Strategic Outlook
    16.2.7. Company G
      16.2.7.1. Company Overview
      16.2.7.2. Segmental Revenue
      16.2.7.3. Product Portfolio
      16.2.7.4. Key Developments
      16.2.7.5. Strategic Outlook
    16.2.8. Company H
      16.2.8.1. Company Overview
      16.2.8.2. Segmental Revenue
      16.2.8.3. Product Portfolio
      16.2.8.4. Key Developments
      16.2.8.5. Strategic Outlook
    16.2.9. Company I
      16.2.9.1. Company Overview
      16.2.9.2. Segmental Revenue
      16.2.9.3. Product Portfolio
      16.2.9.4. Key Developments
      16.2.9.5. Strategic Outlook
    16.2.10. Company J
      16.2.10.1. Company Overview
      16.2.10.2. Segmental Revenue
      16.2.10.3. Product Portfolio
      16.2.10.4. Key Developments
      16.2.10.5. Strategic Outlook
Chapter 17. Go-To-Market Strategy

Research Methodology

We follow a robust research methodology to analyze the market in order to provide our clients with qualitative and quantitative analysis which has a very low or negligible deviance. Extensive secondary research supported by primary data collection methods help us to thoroughly understand and gauge the market. We incorporate both top-down and bottom-up approach for estimating the market. The below mentioned methods are then adopted to triangulate and validate the market.

Secondary data collection and interpretation

Secondary research includes sources such as published books, articles in journals, news media and published businesses, government and international body publications, and associations. Sources also include paid databases such as Hoovers, Thomson Reuters, Passport and others. Data derived through secondary sources is further validated through primary sources. The secondary sources also include major manufacturers mapped on the basis of revenues, product portfolios, and sales channels.

Primary data collection

Primary data collection methods include conducting interviews with industry experts and various stakeholders across the supply chain, such as raw material suppliers, manufacturers, product distributors and customers. The interviews are either telephonic or face-to-face, or even a combination of both. Prevailing trends in the industry are gathered by conducting surveys. Primary interviews also help us to understand the market drivers, restraints and opportunities, along with the challenges in the market. This method helps us in validating the data gathered through secondary sources, further triangulating the data and developing it through our statistical tools. We generally conduct interviews with -

  • CEOs, Directors, and VPs
  • Sales and Marketing Managers
  • Plant Heads and Manufacturing Department Heads
  • Product Specialists

Supply Side and Demand Side Data Collection

Supply side analysis is based on the data collected from the manufacturers and the product providers in terms of their segmental revenues. Secondary sources for this type of analysis include company annual reports and publications, associations and organisations, government publications and others.

Demand side analysis is based upon the consumer insights who are the end users of the particular product in question. They could be an individual user or an organisation. Such data is gathered through consumer surveys and focused group interviews.

Market Engineering

As a primary step, in order to develop the market numbers we follow a vigorous methodology that includes studying the parent market of the niche product and understanding the industry trends, acceptance among customers of the product, challenges, future growth, and others, followed by further breaking down the market under consideration into various segments and sub-markets. Additionally, in order to cross-validate the market, we also determine the top players in the market, along with their segmental revenues for the said market. Our secondary sources help us to validate the market share of the top players. Using both the qualitative and quantitative analysis of all the possible factors helps us determine the market numbers which are inclined towards accuracy.

Request a detailed Research Methodology for the market.

Request Customization or Sample Report

To request a sample report or for any inquiry regarding this report, please fill out the form below

Yes, I have read the Privacy Policy.

Related Reports






latest reports